Nova Patents
ATE101342T1

Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Abstract

The present invention relates to the use of certain prostaglandin derivatives for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension. It also relates to a respective opthalmological composition.

Term

Term ended

Projected expiry passed 6 September 2009, 17 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

90 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
8803110SwedenA
8803855SwedenA

Members90

Family members, oldest first
DocumentOfficeKind
SE8803110D0SwedenD0
WO9002553A1World Intellectual Property Organization (WIPO)A1
AU4189889AAustraliaA
EP0364417A1European Patent Office (EPO)A1
DK112190ADenmarkA
DK112190D0DenmarkD0
FI902258A0FinlandA0
NO901987D0NorwayD0
JPH03501025AJapanA
AU625096B2AustraliaB2
EP0569046A1European Patent Office (EPO)A1
EP0364417B1European Patent Office (EPO)B1
AT101342TAustriaT
ATE101342T1This recordAustriaT1
US5296504AUnited States of AmericaA
DE68913000D1GermanyD1
US5321128AUnited States of AmericaA
DE68913000T2GermanyT2
FI92690BFinlandB
ES2062102T3SpainT3
FI92690CFinlandC
US5422368AUnited States of AmericaA
US5422369AUnited States of AmericaA
HK159095AHong Kong, ChinaA
HU211593A9HungaryA9
JPH08109132AJapanA
US5578618AUnited States of AmericaA
US5627208AUnited States of AmericaA
NL970039I1Netherlands (Kingdom of the)I1
JP2721414B2JapanB2
JPH1081624AJapanA
NL970039I2Netherlands (Kingdom of the)I2
US5849791AUnited States of AmericaA
JP2955213B2JapanB2
US6030999AUnited States of AmericaA
BR1100030ABrazilA
US6187813B1United States of AmericaB1
US2001014693A1United States of AmericaA1
US6417230B2United States of AmericaB2
EP1224934A2European Patent Office (EPO)A2
EP1224935A2European Patent Office (EPO)A2
EP1225168A2European Patent Office (EPO)A2
US6429226B1United States of AmericaB1
EP0569046B1European Patent Office (EPO)B1
AT227576TAustriaT
ATE227576T1AustriaT1
US2002173525A1United States of AmericaA1
DE68929435D1GermanyD1
HK1048106AHong Kong, ChinaA
HK1048106A1Hong Kong, ChinaA1
EP1224934A3European Patent Office (EPO)A3
EP1224935A3European Patent Office (EPO)A3
EP1225168A3European Patent Office (EPO)A3
HK1048251AHong Kong, ChinaA
HK1048251A1Hong Kong, ChinaA1
EP1300149A2European Patent Office (EPO)A2
EP1300150A2European Patent Office (EPO)A2
EP1300151A2European Patent Office (EPO)A2
EP1300149A3European Patent Office (EPO)A3
EP1300150A3European Patent Office (EPO)A3
EP1300151A3European Patent Office (EPO)A3
ES2186670T3SpainT3
DE68929435T2GermanyT2
US2003166729A1United States of AmericaA1
DE1300150T1GermanyT1
US2003181493A1United States of AmericaA1
EP1348437A2European Patent Office (EPO)A2
ES2193901T1SpainT1
EP1348437A3European Patent Office (EPO)A3
EP0364417B2European Patent Office (EPO)B2
DE03014533T1GermanyT1
US2004167190A1United States of AmericaA1
ES2213504T1SpainT1
EP0364417B9European Patent Office (EPO)B9
DE68913000T3GermanyT3
DK200401645ADenmarkA
ES2062102T5SpainT5
JP3612178B2JapanB2
DK175842B1DenmarkB1
DK176053B1DenmarkB1
US7163959B2United States of AmericaB2
EP1225168B1European Patent Office (EPO)B1
AT420857TAustriaT
ATE420857T1AustriaT1
DE68929563D1GermanyD1
ES2317964T3SpainT3
LU91541I2LuxembourgI2
EP1225168B2European Patent Office (EPO)B2
ES2317964T5SpainT5
EP1225168B8European Patent Office (EPO)B8